[CLSTR]
< Back to situations

[ORGANIZATION]

American Academy of Neurology

Featured in 19 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [ES] [IT]

Alzheimer's research: Detection, trials, and efficacy debate

19 clusters · 76 sources · last updated

Latest: Neuroscience research reveals new insights into Alzheimer's and Parkinson's

Research into Alzheimer’s disease continues to evolve, focusing on early detection, molecular mapping, and the physiological breadth of the condition. While previous efforts emphasized biomarkers and AI-driven diagnostic

[QUIET] [HEALTH] [AL] [HN] [PY]

Rising cardiovascular risks in younger populations

5 clusters · 34 sources · last updated

Latest: Cardiovascular health risks: Stress and cholesterol highlighted by experts

Medical experts continue to raise alarms regarding the increasing prevalence of cardiovascular issues among younger populations. While cardiovascular diseases remain a leading cause of death globally, specialists note th

[QUIET] [HEALTH] [US]

Updated migraine prevention clinical guidelines

3 clusters · 12 sources · last updated

Latest: Migraine treatment guidelines and research updates

The American Academy of Neurology (AAN) and the American Headache Society (AHS) have released updated clinical practice guidelines for migraine prevention in adults, marking the first major update to these recommendation

[QUIET] [HEALTH] [CA] [US]

TIA and dementia risk correlation study

2 clusters · 4 sources · last updated

Latest: Mini-strokes linked to higher long-term dementia risk

Research published in the journal Neurology indicates a significant correlation between transient ischemic attacks (TIAs), or mini-strokes, and an increased long-term risk of dementia. Analyzing approximately 20 years o

[QUIET] [HEALTH] [US]

Quantum BioPharma Lucid-MS development

2 clusters · 5 sources · last updated

Latest: Quantum BioPharma receives FDA clearance for Lucid-MS Phase 2 trials

Quantum BioPharma is developing Lucid-MS, an investigational drug candidate designed to treat multiple sclerosis (MS) by directly inhibiting demyelination. The treatment targets the enzyme peptidyl arginine deiminase 2 (

[QUIET] [HEALTH]

Research on stroke and cardiovascular risk factors

2 clusters · 4 sources · last updated

Latest: Physical activity and blood type linked to stroke and heart attack risks

Medical research has increasingly focused on the genetic and lifestyle factors contributing to stroke and cardiovascular risks. Initial reports highlighted the distinction between ischemic and hemorrhagic strokes and ide

Also covered in